The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH), including lateral and median lobe hyperplasia, in men 45 years of age or older.
The UroLift System should not be used if you have:
Most patients do not typically require a catheter post-procedure, but it is possible that you may. If needed, the catheter typically only stays in for an average of about one day.
Recovery times vary but patients typically experience rapid symptom relief and a return to normal activity within a few days. Your doctor will discuss any restrictions in your specific situation.
Most common adverse events reported include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
In the large, pivotal study, there were no reported instances of new, sustained erectile or ejaculatory dysfunction following a UroLift System procedure.1
Non-clinical testing has demonstrated that the UroLift Implant is MR Conditional. That means that you can be safely scanned in an MR system meeting the following conditions:
Under the scan conditions defined above, the UroLift Implant is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning (i.e., per pulse sequence).
In non-clinical testing, the image artifact caused by the device extends approximately 15 mm from the UroLift Implant when imaged with a gradient echo pulse sequence and a 3.0 Tesla MRI system
Patient implant cards are provided to inform the patient that the UroLift implant is MR Conditional and can safely be scanned only under specific MR conditions.
If you have any questions about MRI safety, please consult your doctor.
To report an adverse event or side effect from the UroLift procedure, please call NeoTract Customer Service at (925) 401-0700.